JP2010195714A5 - - Google Patents

Download PDF

Info

Publication number
JP2010195714A5
JP2010195714A5 JP2009042671A JP2009042671A JP2010195714A5 JP 2010195714 A5 JP2010195714 A5 JP 2010195714A5 JP 2009042671 A JP2009042671 A JP 2009042671A JP 2009042671 A JP2009042671 A JP 2009042671A JP 2010195714 A5 JP2010195714 A5 JP 2010195714A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
substance
derivative
composition according
hyp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009042671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010195714A (ja
JP5560570B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009042671A priority Critical patent/JP5560570B2/ja
Priority claimed from JP2009042671A external-priority patent/JP5560570B2/ja
Publication of JP2010195714A publication Critical patent/JP2010195714A/ja
Publication of JP2010195714A5 publication Critical patent/JP2010195714A5/ja
Application granted granted Critical
Publication of JP5560570B2 publication Critical patent/JP5560570B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009042671A 2009-02-25 2009-02-25 創傷治療用医薬組成物 Expired - Fee Related JP5560570B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009042671A JP5560570B2 (ja) 2009-02-25 2009-02-25 創傷治療用医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009042671A JP5560570B2 (ja) 2009-02-25 2009-02-25 創傷治療用医薬組成物

Publications (3)

Publication Number Publication Date
JP2010195714A JP2010195714A (ja) 2010-09-09
JP2010195714A5 true JP2010195714A5 (enExample) 2012-01-05
JP5560570B2 JP5560570B2 (ja) 2014-07-30

Family

ID=42820835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009042671A Expired - Fee Related JP5560570B2 (ja) 2009-02-25 2009-02-25 創傷治療用医薬組成物

Country Status (1)

Country Link
JP (1) JP5560570B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5459826B2 (ja) * 2009-03-03 2014-04-02 林兼産業株式会社 皮膚線維芽細胞におけるエラスチン産生促進剤及び血管内皮細胞の増殖促進剤
JP6709440B2 (ja) * 2018-06-08 2020-06-17 学校法人福岡大学 肥厚性瘢痕の形成抑制用組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0822819B2 (ja) * 1986-02-28 1996-03-06 ハフスルンド ナイコメド アクチスカベット 細胞生長調節作用を有するジペプチドを含有する薬学的製剤
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
JP2002255847A (ja) * 2001-02-26 2002-09-11 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む機能性食品および医薬品
JP2003137807A (ja) * 2001-11-01 2003-05-14 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤
GB0313644D0 (en) * 2003-06-12 2003-07-16 Univ Bristol Inhibition of infection
JP2005289819A (ja) * 2004-03-31 2005-10-20 Nippon Meat Packers Inc 皮膚組織の再生及び肌質改善効果のあるペプチド、並びに該ペプチドを含有する食品、医薬品、又は外用剤
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤

Similar Documents

Publication Publication Date Title
JP7686578B2 (ja) 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
US20160136231A1 (en) Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
CN114206325B (zh) 用于生成一氧化氮的方法和组合物及其用途
JP2008044951A5 (enExample)
JP2016516808A5 (enExample)
HRP20220929T3 (hr) Sastav za inhalaciju koji sadrži aklidinij za liječenje astme
HRP20170358T1 (hr) Inhibitori histonskih demetilaza
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP2009102342A5 (enExample)
JP2013516482A5 (enExample)
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
HRP20171048T1 (hr) Novi agonisti angiotenzinskog receptora tipa 2 (at2) i njihove upotrebe
JP2023526584A (ja) Sars-cov及びsars-cov-2の治療に使用するための一酸化窒素または一酸化窒素放出組成物
JP2023526583A (ja) 結核を治療及び抑制するための方法及び組成物
IL265761B2 (en) Oral terlipressin compositions for use in treatment of ascites
EP4665372A1 (en) New multi-functional oligopeptides
JP2006527234A5 (enExample)
JP2010514834A5 (enExample)
EA201591768A1 (ru) Дозированные препараты в качестве модуляторов опиоидного рецептора
JP2013542954A5 (enExample)
AU2015287947B2 (en) Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition
JP2010195714A5 (enExample)
RU2013157398A (ru) Композиция
JP2020531586A5 (enExample)
CN105658202A (zh) 齐留通乳膏剂型的局部用抗炎症药学组合物